XTPL published its financial results for 2023 during a video conference on 26 April. The company generated total revenues of PLN 15.5 million in 2023, including PLN 13.4 million in revenues from the sale of products and services. This is the highest result in the history of the company’s development and an increase of 21% […]
MoreOncoSNAAT is a key project for Genomtec from the perspective of increasing the company’s value and a potential M&A transaction. For this project, the Company has secured funding in excess of PLN 10 million, which was successfully raised from the Company’s shareholders and a foreign investor. These funds guarantee the acceleration of the work. The […]
MoreWrocław-based biopharmaceutical company Biotts has filed a patent application for transdermal semaglutide and other GLP-1 molecules in the US and plans to launch the finished product by the end of 2026. According to Reuters, the market for semaglutide and similar drugs using GLP-1 analogues will reach $100 billion in annual sales this decade. The company […]
More,,Investors love to earn money with him, scientists spread their wings with him, and their inventions bring millions of dollars. Konrad Pankiewicz, with his open mind and ego in control, is fishing for pearls in an academic crucible.’’ This is what the headline of the July 2017 article published on the Puls Biznesu portal says. […]
More
The development of a nanotechnology startup requires taking effective action on many fronts: R&D activities, cooperation with international patent office in the field of intellectual property protection, fundraising, establishment of contacts with scientific and industry partners at home and abroad. In all these areas we can count on the great support and active involvement of the Leonarto team. The way the Leonarto team works, perfectly reflects the meaning of the phrase “smart money”.
Leonarto is for Bioavlee an invaluable partner in formulating and implementing strategic plans towards sustainable development. The focus on providing an atmosphere of openness that supports unfettered exchange of ideas, views and experiences are the features of our daily relationships. The support and advice of an experienced team of specialists at Leonarto invariably turn out to be very useful for us in building strategic advantages and key operational improvements. The existing cooperation with Leonarto has brought Bioavlee benefits beyond our expectations.
The transition from idea to product (Pregnabit) required a combination of competences and resources from many areas. Getting to the stage where we are today would not be possible without the professional and relational support of the Leonarto team.
Leonarto is primarily professional entrepreneurs. A flesh and blood business people hardened in market battles. They are people who have gone all the way in building companies from scratch, and they understand the obstacles that are lurking on the way. Thanks to that their support is real. There is no place for purely theoretical, academic mentoring here. We are really helped in moving our business to the wide waters.
Due to the achievements to date in supporting the development of early-stage technology companies in the field of medical solutions, the Leonarto fund was the natural choice for Genomtec. Thanks to the experienced Leonarto team, Genomtec was able to significantly accelerate the development of its technology, and also obtained valuable support in the area of intellectual property protection and development of the Company’s market strategy.
Through marketing and business support, cooperation with Leonarto has allowed us to accelerate the commercialization process and the expansion of sales and business development teams. As a VC fund, Leonarto has a very partnership approach to start-ups and provides invaluable contacts in the capital market.
Leonarto support allows us to look far into the future, refine the strategy and answer difficult questions. In addition to the financial background, we gained a partner who willingly shares his knowledge, experience and business know-how. The vision of a global company has become a plan. Together with Leonarto, we started to implement it.
Every company at an early stage of development struggles with the basic paradox about how to survive the coming months, and at the same time develop the organization towards the strategic goals. Leonarto managers understand these challenges perfectly, they approach business realistically and ambitiously. They see the current problems that we face every day and support us in creating long-term priorities. What we particularly value in cooperation with Leonarto is directness and honesty. However, in business there is nothing for free: Leonarto gives a lot, but also demands a lot.
Precisely selected Leonarto | one companies operate in areas with very high growth potential.
